General Health

Dr. Melody Rodarte: Breaking Barriers and Transforming Healthcare in Arizona - Wins Phoenix Magazine TOP DOC for Sixth Year

Retrieved on: 
Friday, March 8, 2024

However, behind this impressive achievement lies a journey marked by perseverance, resilience, and a steadfast commitment to shatter stereotypes.

Key Points: 
  • However, behind this impressive achievement lies a journey marked by perseverance, resilience, and a steadfast commitment to shatter stereotypes.
  • View the full release here: https://www.businesswire.com/news/home/20240308041333/en/
    Reflecting on her path to success, Dr. Rodarte recalls facing skepticism and doubt, particularly as a female, first-generation college-bound student and ethnic minority.
  • "Words are powerful," Dr. Rodarte emphasizes, underscoring the importance of self-belief and resilience in the face of adversity.
  • From weight loss and nutrition to internal medicine and aesthetics, every aspect of patient well-being is meticulously considered and addressed.

New Viz.ai Study Demonstrates Reduced Mortality Rates in Patients with Pulmonary Embolism

Retrieved on: 
Thursday, March 7, 2024

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced clinical data validating the impact of the Viz PE Solution in the management and outcomes of patients with pulmonary embolism (PE).

Key Points: 
  • Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced clinical data validating the impact of the Viz PE Solution in the management and outcomes of patients with pulmonary embolism (PE).
  • The data was presented during the 2024 AVF (American Venous Forum) by Jacob Shapiro, M.D., vascular surgeon at TriHealth in Cincinnati, OH.
  • View the full release here: https://www.businesswire.com/news/home/20240307999862/en/
    The real-world study, "Shorter Time to Assessment and Anticoagulation with Decreased Mortality in Patients with Pulmonary Embolism Following Implementation of Artificial Intelligence Software," evaluated the clinical impact of the Viz PE Solution on time to assessment, time to anticoagulation, and patient outcomes at TriHealth.
  • The study found that implementation of the AI-powered solution combined with PERT activation significantly improved time to assessment and time to anticoagulation with a 74% reduction in in-hospital mortality risk.

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024

Retrieved on: 
Thursday, March 7, 2024

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system, today announced that it will report financial results for the fourth quarter and full year 2023 on Thursday, March 21, 2024.

Key Points: 
  • Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system, today announced that it will report financial results for the fourth quarter and full year 2023 on Thursday, March 21, 2024.
  • Management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
  • A live audio webcast and an archive of the presentation will be available through the Investors page of Hyperfine, Inc.’s corporate website at https://investors.hyperfine.io/ .
  • Participants are encouraged to register more than 15 minutes before the start of the call.

Soleo Health Celebrates 10 Years of Simplifying Complex Care for Patients

Retrieved on: 
Thursday, March 7, 2024

Soleo Health , a national leader in complex specialty pharmacy services, recently marked its 10th anniversary on February 24, 2024.

Key Points: 
  • Soleo Health , a national leader in complex specialty pharmacy services, recently marked its 10th anniversary on February 24, 2024.
  • Led by Chief Executive Officer Drew Walk and Chief Commercial Officer Craig Vollmer, Soleo Health was founded on the commitment to simplify complex care for patients.
  • Over the past decade, Soleo Health has become one of the fastest-growing independent specialty pharmacies, solidifying its position as a leading provider of complex specialty pharmacy services.
  • “Looking ahead, we remain dedicated to defining the unique requirements of complex specialty pharmacy, focusing on patients with complex, rare and ultra-rare diseases,” explained Walk.

Johnson & Johnson Completes Acquisition of Ambrx

Retrieved on: 
Thursday, March 7, 2024

“We’re pleased to welcome Ambrx’s talented scientific team and proprietary ADC platform to Johnson & Johnson.

Key Points: 
  • “We’re pleased to welcome Ambrx’s talented scientific team and proprietary ADC platform to Johnson & Johnson.
  • “This significant opportunity sets the stage for advancing next generation ADCs with the aim of delivering differentiated solid tumor therapies that improve patients’ lives.”
    The acquisition presents a distinct opportunity for Johnson & Johnson to design, develop and commercialize targeted oncology therapeutics.
  • “The Ambrx team has developed a promising pipeline and ADC platform that will be a strong complement and strategic fit to our oncology innovation strategy,” said Biljana Naumovic, Worldwide Vice President, Oncology, Johnson & Johnson Innovative Medicine.
  • This acquisition underscores our ambition to deliver enhanced, precision biologics to transform the treatment of cancers, including prostate cancer.”

Manifest MedEx Now Exchanging Real-Time Health Data Under the CalHHS Data Exchange Framework for Participants

Retrieved on: 
Thursday, March 7, 2024

Manifest MedEx (MX), the largest nonprofit qualified health information organization (QHIO) for the CalHHS Data Exchange Framework (DxF), announced today it is securely exchanging permitted health data in real time on behalf of DxF participants, including with other QHIOs, marking a new milestone in the implementation of the DxF.

Key Points: 
  • Manifest MedEx (MX), the largest nonprofit qualified health information organization (QHIO) for the CalHHS Data Exchange Framework (DxF), announced today it is securely exchanging permitted health data in real time on behalf of DxF participants, including with other QHIOs, marking a new milestone in the implementation of the DxF.
  • The nearly 200 organizations that selected Manifest MedEx as their data exchange intermediary in the DxF Participant Directory are now successfully meeting their health data sharing obligations under AB 133, state law that requires most healthcare entities in California to exchange health and social services information beginning this year.
  • In addition to clinical information from providers’ electronic health record systems, Manifest Medex shares DxF-required administrative health data from payers, including adjudicated claims and encounters from health insurers and health plans.
  • Organizations interested in using Manifest MedEx as their DxF intermediary should reach out to Manifest MedEx at [email protected] and ensure they have updated their organization listing in the DxF Participant Directory.

QT Imaging Pioneers Patient-Centric Breast Imaging Technology through Strategic Partnership

Retrieved on: 
Thursday, March 7, 2024

The QTI Breast Acoustic CT™ System, featuring the trademarked Breast ACT™ technology, is an advancement in breast imaging.

Key Points: 
  • The QTI Breast Acoustic CT™ System, featuring the trademarked Breast ACT™ technology, is an advancement in breast imaging.
  • Lastly, this NIH-funded technology represents a significant advancement in healthcare imaging, setting a new standard in breast imaging excellence.
  • “The QTI Breast Acoustic CT™ System represents a leap forward in patient-centric breast imaging.
  • This strategic partnership marks a significant achievement for QTI and serves as a testament to the advancements in breast imaging technology.

Nurse and Physician Workplace Engagement Seeing Signs of Recovery—While Key Roles Like Managers Still Struggle

Retrieved on: 
Thursday, March 7, 2024

Employee engagement is a critical measure for organizations as it impacts almost every facet of operations from safety, health outcomes, staff retention and financial sustainability.

Key Points: 
  • Employee engagement is a critical measure for organizations as it impacts almost every facet of operations from safety, health outcomes, staff retention and financial sustainability.
  • Key findings include:
    Nationally, employee engagement is on the way up for the first time since the pandemic, rising from 4.02 to 4.04 (out of 5).
  • Employee engagement is a measure related to an employee’s connection to and satisfaction with the workplace, intent to stay, and a likelihood to recommend their employer.
  • Nearly half of all healthcare roles improved on engagement last year, with physicians, registered nurses, security, licensed technical and skilled maintenance roles showing gains.

The Access to Advanced Health Institute Receives up to $12.7 Million to Develop Novel NanoAlum Adjuvant Formulation for Better Protection Against Tuberculosis and Pandemic Influenza

Retrieved on: 
Thursday, March 7, 2024

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240307661956/en/
    This five-year prototype project will support AAHI’s development and optimization of “NanoAlum” – a novel nanoparticle adjuvant formulation, made from aluminum salts (“alum”).
  • Alum-adjuvanted vaccines have been less effective against diseases such as tuberculosis and influenza, which are more complex to target and can be challenging to manufacture because they require special sterilization methods.
  • AAHI’s NanoAlum formulation changes the size, shape, and charge of alum particles to enhance specific immune responses for better vaccine protection against complex diseases.
  • AAHI’s prototype project for MCDC will pair the combined 3M-052 and NanoAlum formulation with tuberculosis and pandemic influenza vaccine antigens.

Europe Contrast Media Agent and Injector System Analysis Report 2024: Increasing Prevalence of Cancer and Cardiovascular Diseases Leading to Upsurge in Demand - Forecasts to 2033 - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 7, 2024

The "Europe Contrast Media Agent and Injector System Market: Analysis and Forecast: 2022-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Contrast Media Agent and Injector System Market: Analysis and Forecast: 2022-2026" report has been added to ResearchAndMarkets.com's offering.
  • The Europe Contrast Media Agent and Injector System market is witnessing robust growth driven by factors such as the increasing prevalence of chronic diseases, rising demand for diagnostic imaging procedures, and advancements in medical imaging technologies.
  • Growth/Marketing Strategy: The Europe contrast media agent and injector system market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint ventures.
  • Competitive Strategy: The Europe contrast media agent and injector system market consists of various leading manufacturers, small-medium enterprises, and emerging startups.